FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2585771041> ?p ?o ?g. }

• W2585771041 abstract "While tumor necrosis factor alpha (TNF-α) inhibitors (TNFi) and other biologics are very effective against autoimmune diseases, they can also cause infectious diseases. Therefore, it is important to clarify whether the TNFi sometimes used to treat patients with rheumatoid arthritis (RA) complicated with human T-lymphotropic virus type-I (HTLV-I) infection have the unintended side effect of promoting HTLV-I proliferation.We used the HTLV-I-infected cell line HCT-5, derived from spinal fluid cells of a patient with HTLV-I associated myelopathy, to evaluate the production of cytokines and chemokines, TNF-α receptor (TNFR), the expression of HTLV-I associated genes, the HTLV-I proviral load (PVL), the expression of HTLV-I structural protein, and apoptosis. We used Jurkat cells as a control.Supernatants of HCT-5 showed time-dependent elevations of IL-6, RANTES and ICAM-1. HCT-5 supernatants treated with infliximab, adalimumab, etanercept (ETN), golimumab and certolizumab pegol showed no significant differences in the levels of these molecules compared to the control. Neither TNFR1 nor TNFR2 expression was altered by any TNFi treatment, relative to phosphate-buffered saline (PBS) treatment, with the exception that TNFR2 was significantly decreased and internalized in HCT-5 cells by ETN treatment. The HTLV-I associated genes Tax and HBZ and the PVL levels were not significantly changed. Immunofluorescence staining of HCT-5 for an HTLV-I-associated protein, GAG, was also not significantly different between any of the TNFi treatments and the PBS treatment. DNA ladders as an index of apoptosis were not detected. Apoptotic cells were not increased by the addition of any TNFi.In vitro, TNFi did not affect the cytokine profiles, expression of associated genes and proteins, proviral load or apoptosis of HCT-5 cells. The results suggested that TNFi treatment of RA patients complicated with HTLV-I might have no effect on HTLV-I infection." @default.
• W2585771041 created "2017-02-10" @default.
• W2585771041 creator A5000492056 @default.
• W2585771041 creator A5001766958 @default.
• W2585771041 creator A5015568967 @default.
• W2585771041 creator A5020500592 @default.
• W2585771041 creator A5022076444 @default.
• W2585771041 creator A5049434794 @default.
• W2585771041 creator A5070326257 @default.
• W2585771041 creator A5081071954 @default.
• W2585771041 creator A5084299259 @default.
• W2585771041 date "2017-02-03" @default.
• W2585771041 modified "2023-10-09" @default.
• W2585771041 title "Tumor necrosis factor alpha inhibitors have no effect on a human T-lymphotropic virus type-I (HTLV-I)-infected cell line from patients with HTLV-I-associated myelopathy" @default.
• W2585771041 cites W1209106218 @default.
• W2585771041 cites W1927190116 @default.
• W2585771041 cites W1966278500 @default.
• W2585771041 cites W1981906666 @default.
• W2585771041 cites W1998789189 @default.
• W2585771041 cites W2000368283 @default.
• W2585771041 cites W2006211307 @default.
• W2585771041 cites W2018410379 @default.
• W2585771041 cites W2024046618 @default.
• W2585771041 cites W2030973107 @default.
• W2585771041 cites W2031500470 @default.
• W2585771041 cites W2038595075 @default.
• W2585771041 cites W2039301421 @default.
• W2585771041 cites W2045167236 @default.
• W2585771041 cites W2057123987 @default.
• W2585771041 cites W2061119643 @default.
• W2585771041 cites W2061294496 @default.
• W2585771041 cites W2065222875 @default.
• W2585771041 cites W2065716796 @default.
• W2585771041 cites W2070208938 @default.
• W2585771041 cites W2071794490 @default.
• W2585771041 cites W2085206112 @default.
• W2585771041 cites W2085746138 @default.
• W2585771041 cites W2088302586 @default.
• W2585771041 cites W2089006005 @default.
• W2585771041 cites W2094831592 @default.
• W2585771041 cites W2120083267 @default.
• W2585771041 cites W2121082919 @default.
• W2585771041 cites W2124378998 @default.
• W2585771041 cites W2129248412 @default.
• W2585771041 cites W2141242051 @default.
• W2585771041 cites W2157155233 @default.
• W2585771041 cites W2164208359 @default.
• W2585771041 cites W2171297959 @default.
• W2585771041 cites W2259896843 @default.
• W2585771041 cites W2297295070 @default.
• W2585771041 cites W2340084730 @default.
• W2585771041 cites W2399778456 @default.
• W2585771041 cites W4245726295 @default.
• W2585771041 doi "https://doi.org/10.1186/s12865-017-0191-2" @default.
• W2585771041 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5292003" @default.
• W2585771041 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28158970" @default.
• W2585771041 hasPublicationYear "2017" @default.
• W2585771041 type Work @default.
• W2585771041 sameAs 2585771041 @default.
• W2585771041 citedByCount "14" @default.
• W2585771041 countsByYear W25857710412017 @default.
• W2585771041 countsByYear W25857710412018 @default.
• W2585771041 countsByYear W25857710412019 @default.
• W2585771041 countsByYear W25857710412020 @default.
• W2585771041 countsByYear W25857710412021 @default.
• W2585771041 countsByYear W25857710412022 @default.
• W2585771041 countsByYear W25857710412023 @default.
• W2585771041 crossrefType "journal-article" @default.
• W2585771041 hasAuthorship W2585771041A5000492056 @default.
• W2585771041 hasAuthorship W2585771041A5001766958 @default.
• W2585771041 hasAuthorship W2585771041A5015568967 @default.
• W2585771041 hasAuthorship W2585771041A5020500592 @default.
• W2585771041 hasAuthorship W2585771041A5022076444 @default.
• W2585771041 hasAuthorship W2585771041A5049434794 @default.
• W2585771041 hasAuthorship W2585771041A5070326257 @default.
• W2585771041 hasAuthorship W2585771041A5081071954 @default.
• W2585771041 hasAuthorship W2585771041A5084299259 @default.
• W2585771041 hasBestOaLocation W25857710411 @default.
• W2585771041 hasConcept C118552586 @default.
• W2585771041 hasConcept C13373296 @default.
• W2585771041 hasConcept C159047783 @default.
• W2585771041 hasConcept C179464577 @default.
• W2585771041 hasConcept C17991360 @default.
• W2585771041 hasConcept C203014093 @default.
• W2585771041 hasConcept C2776090121 @default.
• W2585771041 hasConcept C2776215756 @default.
• W2585771041 hasConcept C2776368728 @default.
• W2585771041 hasConcept C2776392238 @default.
• W2585771041 hasConcept C2776914184 @default.
• W2585771041 hasConcept C2777138892 @default.
• W2585771041 hasConcept C2777226972 @default.
• W2585771041 hasConcept C2777575956 @default.
• W2585771041 hasConcept C2777604421 @default.
• W2585771041 hasConcept C2780132546 @default.
• W2585771041 hasConcept C2780775167 @default.
• W2585771041 hasConcept C2781290027 @default.
• W2585771041 hasConcept C61879462 @default.
• W2585771041 hasConcept C71924100 @default.
• W2585771041 hasConcept C8891405 @default.
• W2585771041 hasConceptScore W2585771041C118552586 @default.

• next